- Home
- MYGN vs SYBT Comparison
MYGN vs SYBT Comparison
Compare MYGN & SYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MYGN | SYBT |
|---|---|---|
| Founded | 1991 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 327.1M | 2.5B |
| IPO Year | 1996 | 2009 |
Fundamental Metrics
Financial Performance| Metric | MYGN | SYBT |
|---|---|---|
| Price | $3.72 | $80.90 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 4 |
| Target Price | $7.64 | ★ $76.00 |
| AVG Volume (30 Days) | ★ 1.6M | 115.7K |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.81% |
| EPS Growth | N/A | ★ 22.11 |
| EPS | N/A | ★ 2.55 |
| Revenue | ★ $771,400,000.00 | $23,406,000.00 |
| Revenue This Year | $6.86 | $17.31 |
| Revenue Next Year | $5.45 | $9.32 |
| P/E Ratio | ★ N/A | $31.27 |
| Revenue Growth | 2.33 | ★ 3.37 |
| 52 Week Low | $2.74 | $61.51 |
| 52 Week High | $8.59 | $89.22 |
Technical Indicators
Market Signals| Indicator | MYGN | SYBT |
|---|---|---|
| Relative Strength Index (RSI) | 59.37 | 50.11 |
| Support Level | $3.53 | $69.44 |
| Resistance Level | $5.42 | $81.82 |
| Average True Range (ATR) | 0.19 | 1.59 |
| MACD | 0.12 | -0.05 |
| Stochastic Oscillator | 96.67 | 66.30 |
Price Performance
Historical ComparisonAbout MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
About SYBT Stock Yards Bancorp Inc.
Stock Yards Bancorp Inc operates as a bank holding company providing commercial banking and wealth management services. Its Commercial Banking segment offers loan and deposit products to consumers and businesses, including retail and mortgage lending, deposit services, online and mobile banking, private banking, commercial and real estate lending, treasury and merchant services, international and correspondent banking, credit cards, and brokerage services through a third-party broker-dealer. Its Wealth Management and Trust (WM&T) segment provides investment management, financial and retirement planning, trust and estate services, and retirement plan management, with WM&T revenue distinguishing the company from similarly sized community banks.